This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Life Stem Genetics Inc. (the “Company”), an emerging innovator in the advancement of Adult Stem Cell therapy announces that the Company's new stock symbol, LIFS, is now active.
The Company is also pleased to release the general details of its recent financing commitment. This financing is for $1 million (the “Private Placement”) of 1,000,000 units (each, a “Unit”) at a price of $1 per Unit. Each Unit will consist of one common share of the Company and one warrant to purchase an additional common share of the Company (each, a “Warrant Share”) at $1 per Warrant Share for a period of one year. The Company is to close the Private Placement within 45 calendar days of this press release.